» Articles » PMID: 28419211

The Inhibitory G Protein α-Subunit, Gαz, Promotes Type 1 Diabetes-Like Pathophysiology in NOD Mice

Abstract

The α-subunit of the heterotrimeric Gz protein, Gαz, promotes β-cell death and inhibits β-cell replication when pancreatic islets are challenged by stressors. Thus, we hypothesized that loss of Gαz protein would preserve functional β-cell mass in the nonobese diabetic (NOD) model, protecting from overt diabetes. We saw that protection from diabetes was robust and durable up to 35 weeks of age in Gαz knockout mice. By 17 weeks of age, Gαz-null NOD mice had significantly higher diabetes-free survival than wild-type littermates. Islets from these mice had reduced markers of proinflammatory immune cell infiltration on both the histological and transcript levels and secreted more insulin in response to glucose. Further analyses of pancreas sections revealed significantly fewer terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL)-positive β-cells in Gαz-null islets despite similar immune infiltration in control mice. Islets from Gαz-null mice also exhibited a higher percentage of Ki-67-positive β-cells, a measure of proliferation, even in the presence of immune infiltration. Finally, β-cell-specific Gαz-null mice phenocopy whole-body Gαz-null mice in their protection from developing hyperglycemia after streptozotocin administration, supporting a β-cell-centric role for Gαz in diabetes pathophysiology. We propose that Gαz plays a key role in β-cell signaling that becomes dysfunctional in the type 1 diabetes setting, accelerating the death of β-cells, which promotes further accumulation of immune cells in the pancreatic islets, and inhibiting a restorative proliferative response.

Citing Articles

Gα-independent and -dependent Improvements With EPA Supplementation on the Early Type 1 Diabetes Phenotype of NOD Mice.

Fenske R, Wienkes H, Peter D, Schaid M, Hurley L, Pennati A J Endocr Soc. 2024; 8(7):bvae100.

PMID: 38831864 PMC: 11146416. DOI: 10.1210/jendso/bvae100.


Activation of Multiple G Protein Pathways to Characterize the Five Dopamine Receptor Subtypes Using Bioluminescence Technology.

Monnich D, Humphrys L, Horing C, Hoare B, Forster L, Pockes S ACS Pharmacol Transl Sci. 2024; 7(3):834-854.

PMID: 38481695 PMC: 10928903. DOI: 10.1021/acsptsci.3c00339.


The prostaglandin E EP3 receptor has disparate effects on islet insulin secretion and content in β-cells in a high-fat diet-induced mouse model of obesity.

Neuman J, Reuter A, Carbajal K, Schaid M, Kelly G, Connors K Am J Physiol Endocrinol Metab. 2024; 326(5):E567-E576.

PMID: 38477664 PMC: 11376488. DOI: 10.1152/ajpendo.00061.2023.


Harnessing prostaglandin E signaling to ameliorate autoimmunity.

Burkett J, Doran A, Gannon M Trends Immunol. 2023; 44(3):162-171.

PMID: 36707339 PMC: 9975049. DOI: 10.1016/j.it.2023.01.004.


Plasma Prostaglandin E Metabolite Levels Predict Type 2 Diabetes Status and One-Year Therapeutic Response Independent of Clinical Markers of Inflammation.

Fenske R, Weeks A, Daniels M, Nall R, Pabich S, Brill A Metabolites. 2022; 12(12).

PMID: 36557272 PMC: 9783643. DOI: 10.3390/metabo12121234.


References
1.
Kimple M, Joseph J, Bailey C, Fueger P, Hendry I, Newgard C . Galphaz negatively regulates insulin secretion and glucose clearance. J Biol Chem. 2007; 283(8):4560-7. DOI: 10.1074/jbc.M706481200. View

2.
Bach J, Mathis D . The NOD mouse. Res Immunol. 1997; 148(5):285-6. DOI: 10.1016/s0923-2494(97)87235-5. View

3.
Maghazachi A . Chemokines activate natural killer cells through heterotrimeric G-proteins: implications for the treatment of AIDS and cancer. FASEB J. 1998; 12(11):913-24. DOI: 10.1096/fasebj.12.11.913. View

4.
Mathis D, Vence L, Benoist C . beta-Cell death during progression to diabetes. Nature. 2001; 414(6865):792-8. DOI: 10.1038/414792a. View

5.
Rabinovitch A, Suarez-Pinzon W . Roles of cytokines in the pathogenesis and therapy of type 1 diabetes. Cell Biochem Biophys. 2007; 48(2-3):159-63. DOI: 10.1007/s12013-007-0029-2. View